A detailed history of Bastion Asset Management Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bastion Asset Management Inc. holds 4,740 shares of TMDX stock, worth $585,674. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,740
Previous 38,336 87.64%
Holding current value
$585,674
Previous $2.4 Billion 86.26%
% of portfolio
0.18%
Previous 1.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

SELL
$56.73 - $79.42 $1.91 Million - $2.67 Million
-33,596 Reduced 87.64%
4,740 $330 Million
Q4 2024

Feb 14, 2025

BUY
$59.28 - $144.9 $2.27 Million - $5.55 Million
38,336 New
38,336 $2.4 Billion

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.93B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Bastion Asset Management Inc. Portfolio

Follow Bastion Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bastion Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bastion Asset Management Inc. with notifications on news.